Lp(a) ≥75 nmol/L has been associated with higher levels of non-culprit plaque rupture and non-culprit thin-cap fibroatheroma (TCFA) in patients with acute myocardial infarction (AMI).
Educational Partners and Supporters
AstraZeneca has provided a sponsorship grant towards this independent programme.
